Repurposing the hERG activator NS-1643 as a ferroptosis-targeting therapeutic against doxorubicin cardiotoxicity.

Saved in:
Bibliographic Details
Title: Repurposing the hERG activator NS-1643 as a ferroptosis-targeting therapeutic against doxorubicin cardiotoxicity.
Authors: Sheng, Xie-Huang1 (AUTHOR), Teng, Lin-Song1,2 (AUTHOR), Wang, Xin-Hui1 (AUTHOR), Jiang, Li-Qi1 (AUTHOR), Sun, Xue-Cheng3 (AUTHOR), Mao, Jin-Long1,4 (AUTHOR) maojinlong@gmail.com, Zhang, Lei1,5 (AUTHOR) qygkzl1818@163.com
Source: Free Radical Biology & Medicine. Jun2026, Vol. 249, p14-26. 13p.
Database: Academic Search Ultimate
Description
ISSN:08915849
DOI:10.1016/j.freeradbiomed.2026.03.014